Search the Newsreel

Dimensional Fund Advisors LP Purchases 256,640 Shares of FuelCell Energy, Inc. $FCEL

Dimensional Fund Advisors LP significantly increased its stake in FuelCell Energy, Inc. (NASDAQ:FCEL) by 459.1% in the first quarter, acquiring an additional 256,640 shares and bringing its total holdings to 312,536 shares valued at approximately $2.04 million. Despite institutional interest, FuelCell Energy reported disappointing …

Does Millicom’s Higher Sales, Lower Profit And New Dividend Shift The Bull Case For TIGO?

6 Green Days In A Row: AbCellera Biologics Stock Is Up 85%

AbCellera Biologics (ABCL) stock has surged 85% over six consecutive trading days, reaching a new 52-week high and adding $1.5 billion to its market value. While its revenue growth is strong at 101.3% over the last twelve months, the company faces profitability challenges with …

ETFs Investing in Cellebrite DI Ltd. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Cellebrite DI Ltd. (CLBT), providing detailed information such as market value, weight, issuer, management style, expense ratio, AUM, price change, relative volume, and 3-year NAV total return for each fund. It aims …

Turkcell Iletisim Hizmetleri A.S. 2026 Q2 - Results - Earnings Call Presentation (NYSE:TKC) 2026-08-14

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 1:00 p.m. ET CALL PARTICIPANTS Investor Relations and Corporate Finance Director - Ozlem YardimChief Executive Officer - Ali Taha KocChief Financial Officer - Kamil Kalyon TAKEAWAYS Revenue -- 71.8 billion Turkish liras, increasing …

Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

Cellebrite (CLBT) CEO gets 339,484-share award and withholds 139,713 shares for taxes

Cellebrite DI Ltd. CEO Thomas E. Hogan received an award of 339,484 ordinary shares on August 11, 2026, after performance conditions from awards granted in September 2025 were met. Subsequently, 139,713 shares were withheld and sold on August 12, 2026, at a weighted average …

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Levi & Korsinsky, LLP has announced an investigation into Cellebrite DI Ltd. (CLBT) following a significant stock drop of over 30% after the company's Q2 2026 results. The investigation focuses on whether Cellebrite made misleading statements regarding its 2026 annual recurring revenue (ARR) and …

Turkcell Iletisim Hizmetleri AS (TKC) (Q2 2026) Earnings Call Highlights: 5G Investments and ...

This article first appeared on GuruFocus. Revenue: Group revenue reached TRY 71.8 billion, up 2.5% year-on-year. EBITDA: TRY 30 billion, with a margin of 41.8%. Net Income: TRY 5.2 billion. Mobile ARPU: TRY 448, with mobile ARPU excluding M2M growing 27% year-on-year. Residential Fiber …

Turkcell (TKC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 1:00 p.m. ET CALL PARTICIPANTS Investor Relations and Corporate Finance Director - Ozlem YardimChief Executive Officer - Ali Taha KocChief Financial Officer - Kamil Kalyon TAKEAWAYS Revenue -- 71.8 billion Turkish liras, increasing …

Cellebrite DI (CLBT) Names Shiven Ramji CEO As Revenue Guidance Is Cut

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Platform Evolution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript

ImmuCell (NASDAQ:ICCC) Announces Earnings Results, Beats Estimates By $0.15 EPS

ImmuCell (NASDAQ:ICCC) reported its earnings results, beating the consensus estimate by $0.15 EPS with reported earnings of $0.20 per share. The biotechnology company also surpassed revenue expectations, bringing in $7.19 million against an anticipated $5.40 million. Despite these positive financial results, the company maintains …

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan Sells 139,713 Shares of Stock

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan sold 139,713 shares of the company's stock for approximately $2.15 million, reducing his direct ownership by 15.02%. The sale comes as Cellebrite's stock fell, trading below its moving averages, and the company recently lowered its 2026 revenue and …

Cellebrite DI Ltd (CLBT) (Q2 2026) Earnings Call Highlights: ARR Misses Guidance, Full-Year ...

This article first appeared on GuruFocus. ARR: Increased 21% to $508 million, missing the bottom end of guidance. Revenue: $131 million, up 16% year-over-year. Subscription Revenue: $119.5 million, up 16%, representing 91% of total revenue. Gross Profit: Increased 16% to $112 million, with a …

Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance

Cellectar Biosciences (CLRB) ownership: Bleichroeder group reports 9.99% equity stake

Bleichroeder entities, led by Bleichroeder LP and Andrew Gundlach, have reported a 9.99% equity stake in Cellectar Biosciences (CLRB), amounting to 808,300 common shares. Bleichroeder LP, a registered investment adviser, holds these shares for various advisory clients, granting them sole voting and dispositive power …

IMMUCELL CORP /DE/ Q2 2026: Revenue $7.19M, EPS $0.2— 10-Q Summary

IMMUCELL CORP /DE/ (ICCC) reported strong second-quarter 2026 results, with revenue reaching $7.19M and diluted EPS of $0.20, significantly up from the previous year. This growth was primarily driven by increased volumes and pricing for its First Defense product, which accounted for over 99% …

ImmuCell Plans About $4.5M Expansion for Calf Health Products

ImmuCell (NASDAQ: ICCC) reported strong Q2 2026 financial results with product sales up 11.5% to $7.2 million and net income rising to $1.8 million, aided by a $2 million legal settlement. The company announced a two-phase, approximately $8.0 million expansion of its First Defense® …

ImmuCell Corporation (ICCC) doubles profit on higher First Defense sales

ImmuCell Corporation reported robust financial results for the first half of 2026, with net income doubling to $3.8 million due to increased First Defense sales and a significant $2.0 million settlement. The company's product sales grew by 20.9% to $17.5 million, largely driven by …

FuelCell Energy (NASDAQ:FCEL) Shares Down 7.1% - Here's What Happened

FuelCell Energy (NASDAQ:FCEL) shares dropped 7.1% on Thursday, closing at $20.13, with trading volume below average. The company reported a significant quarterly loss and lower-than-expected revenue. Analyst sentiment is mixed, resulting in a consensus "Hold" rating and an average price target of $22.83.

Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply

Turkcell Iletisim Hizmetleri AS (NYSE:TKC) Issues Quarterly Earnings Results

Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)

Cellebrite DI Ltd. (CLBT) experienced a significant 33% stock drop post-earnings, which the author believes is an overreaction. Despite missing Q2 guidance for ARR and revenue growth, and facing management transition and slower Inseyets conversions, the company maintains strong core products, high retention, and …

Cellebrite DI Releases Q2 2026 Financial Results

Cellebrite DI Ltd. reported mixed Q2 2026 financial results, with earnings per share meeting expectations at $0.11, while revenue of $131.1M slightly missed the $131.9M estimate. Despite the revenue miss, the company showed strong year-over-year growth, with total revenue up 16.0% and subscription services …

Transcript : Turkcell Iletisim Hizmetleri A.S., Q2 2026 Earnings Call, Aug 13, 2026

AbCellera Biologics Inc. • Robinhood Token (ABCL) Price Prediction for 2026 to 2031

This article provides price predictions for AbCellera Biologics Inc. • Robinhood Token (ABCL) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for ABCL's price, with significant potential ROI over the years, …

Cellectar Biosciences Releases Q2 2026 Financial Results

Cellectar Biosciences (CLRB) reported a wider-than-expected diluted loss of $0.57 per share for Q2 2026, missing analyst estimates. Despite this, the net loss of $6.9M represents an 83.2% improvement year-over-year. The clinical-stage biopharmaceutical company maintains strong analyst support for its oncology pipeline.

Turkcell Iletisim Hizmetleri Q2 Earnings Fall, Revenue Rises

Turkcell mobile base tops 40 million after 243,000 additions

Turkcell announced its Q2 2026 earnings, reporting consolidated revenues of TRY 71.8 billion, a 2.5% year-on-year increase, and an EBITDA of TRY 30.0 billion with a 41.8% margin. The company's mobile subscriber base exceeded 40 million for the first time, adding 243,000 subscribers in …

Turkcell Iletisim Hizmetleri: Second Quarter 2026 Results

Diversified and Resilient Business Model Delivers Steady Growth ISTANBUL, August 13, 2026--(BUSINESS WIRE)--Turkcell (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim Hizmetleri A.S. (the "Company" or "Turkcell") and its subsidiaries and associates (together referred to as …

Turkcell Iletisim Hizmetleri A.S. Maintains Earnings Guidance for the Year 2026

Turkcell Iletisim Hizmetleri A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Diversified and Resilient Business Model Delivers Steady Growth ISTANBUL, August 13, 2026--(BUSINESS WIRE)--Turkcell (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim Hizmetleri A.S. (the "Company" or "Turkcell") and its subsidiaries and associates (together referred to as …

Cellebrite DI Ltd. Stock Analysis: 5-Day Bearish Momentum Insights

Cellebrite DI Ltd. (CLBT) stock has crashed to $10.22 following a post-earnings decline, placing it deep in oversold territory according to its RSI readings across multiple timeframes. The company missed annual recurring revenue expectations due to delayed transactions and slower customer migration gains, leading …

Does Power‑Generating Carbon Capture Tech Shift the Bull Case for FuelCell Energy (FCEL)?

FuelCell Energy's new power-generating carbon capture technology, which integrates into plant exhaust streams to reduce emissions and produce electricity, reinforces the company's investment thesis. While this innovation offers potential for an additional revenue stream and scalability, the immediate impact on its financial picture remains …